ZiWei Jiang

ZiWei Jiang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MHMinhua Hu
Minhua Hu
HYHongsong Yan
Hongsong Yan
HLHaishan Li
Haishan Li
YFYuanlan Feng
Yuanlan Feng
WSWeipeng Sun
Weipeng Sun
HDHang Dong
Hang Dong
Curcuma has been used as an adjuvant treatment for osteosarcoma (OS) due to its anticancer compounds. However, the underlying mechanism remains unclear. Therefore, this study aimed to explore the mechanism of action of curcuma in the treatment of OS using network pharmacology and molecular docking. In this study, anticancer compounds were obtained from relevant literature, and curcuma-related targets and OS treatment targets were obtained from public databases. Protein‒protein interaction networks were constructed to screen out the hub genes using the STRING database and Cytoscape software. Cluster analysis of the protein modules was then performed using the Cytoscape MCODE plugin. Furthermore, Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed for common targets among curcuma targets and OS-related targets using the DAVID database. Finally, molecular docking was performed, and the results were verified by Auto dock Tool and PyMOL software. Our research identified 11 potential active compounds, 141 potential therapeutic targets and 14 hub genes for curcuma. AKT1, TNF, STAT3, EGFR, and HSP90AA1 were the key targets closely related to the PI3K/Akt signaling pathways, HIF-1 signaling pathways, ErbB signaling pathways, and FOXO signaling pathways, which are involved in angiogenesis, cancer cell proliferation, metastasis, invasion, and chemotherapy resistance in the microenvironment of OS. Molecular docking suggested that the core compound had a strong affinity for key targets, with a binding energy of less than – 5 kJ/mol. The study showed that curcuma-mediated treatment of OS was a complex process involving multiple compounds, targets, and pathways. This study will enhance the understanding of how curcuma affects the proliferation and invasion of OS cells and reveal the potential molecular mechanism underlying the effect of curcuma on OS lung metastasis and chemotherapy resistance.

1 June 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
WSWeipeng Sun
Weipeng Sun
MLMinying Li
Minying Li
YZYan Zhang
Yan Zhang
YHYingjie Huang
Yingjie Huang
QZQunzhang Zhan
Qunzhang Zhan
ZJZiWei Jiang
ZiWei Jiang
Osteogenesis and angiogenesis acts as an essential role in repairing large tibial defects (LTDs). Total flavonoids of rhizoma drynariae (TFRD), a traditional Chinese medicinal herb, is reported to show anabolic effects on fracture healing. However, whether TFRD could improve the bone formation and angiogenesis in LTDs remains unknown. The purpose of this study was to evaluate the effect of TFRD on bone formation and angiogenesis in LTDs in distraction osteogenesis (DO). Using a previously established fracture model, LTD rats was established with circular external fixator (CEF). All rats then randomly divided into TFRD low dosage group (with DO), TFRD medium dosage group (with DO), TFRD high dosage group (with DO), model group (with DO) and blank group (without DO). Twelve weeks after treatment, according to X-ray and Micro-CT, TFRD groups (especially in medium dosage group) can significantly promote the formation of a large number of epiphyses and improve new bone mineralization compared with model group, and the results of HE and Masson staining and in vitro ALP level of BMSC also demonstrated the formation of bone matrix and mineralization in the TFRD groups. Also, angiographic imaging suggested that total flavonoids of TFRD was able to promote angiogenesis in the defect area. Consistently, TFRD significantly increased the levels of BMP-2, SMAD1, SMAD4, RUNX-2, OSX and VEGF in LTD rats based on ELISA and Real-Time PCR. In addition, we found that ALP activity of TFRD medium dosage group reached a peak after 10 days of induction through BMSC cell culture in vitro experiment. TFRD promoted bone formation in LTD through activation of BMP-Smad signaling pathway, which provides a promising new strategy for repairing bone defects in DO surgeries.

31 May 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
WSWeipeng Sun
Weipeng Sun
MLMinying Li
Minying Li
LXLei Xie
Lei Xie
ZMZhexing Mai
Zhexing Mai
YZYan Zhang
Yan Zhang
ZJZiWei Jiang
ZiWei Jiang
Drynariae Rhizoma (DR) has been demonstrated to be effective in promoting fracture healing in clinical use. In the study, we tried to predicate potential signaling pathways and active ingredients of DR via network pharmacology, uncover its regulation mechanism to improve large bone defects by in vivo and in vitro experiment. We total discovered 18 potential active ingredients such as flavonoids and 81 corresponding targets, in which mitogen-activated protein kinase (MAPK) signaling pathway has the highest correlation with bone defects in pathway and functional enrichment analysis. Therefore, we hypothesized that flavonoids in DR improve large bone defects by activating MAPK signaling pathway. Animal experiments were carried out and all rats randomly divided into TFDR low, medium, and high dosage group, model group and control group. 12 weeks after treatment, according to X-ray and Micro-CT, TFDR medium dosage group significantly promote new bone mineralization compared with other groups. The results of HE and Masson staining and in vitro ALP level of BMSC also demonstrated the formation of bone matrix and mineralization in the TFDR groups. Also, angiographic imaging suggested that flavonoids in DR promoting angiogenesis in the defect area. Consistently, TFDR significantly enhanced the expression of BMP-2, RUNX-2, VEGF, HIF-1 in large bone defect rats based on ELISA and Real-Time PCR. Overall, we not only discover the active ingredients of DR in this study, but also explained how flavonoids in DR regulating MAPK signaling pathway to improve large bone defects.

1 February 2026 in Bioactive Materials
Verified
Journal Article
Open access
WSWeipeng Sun
Weipeng Sun
QLQing Lin
Qing Lin
BZBiyi Zhao
Biyi Zhao
MLMinying Li
Minying Li
JXJiacong Xiao
Jiacong Xiao
ZJZiWei Jiang
ZiWei Jiang
Recent studies have challenged the notion that bone tissue lacks lymphatic vessels, highlighting their essential role in bone regeneration. Effective bone repair relies on the interplay of osteogenesis, angiogenesis, and lymphangiogenesis. Here, we present a three dimensional-printed biomimetic Gelatin methacryloyl/icariin@Mesoporous silica nanoparticle/Hydroxyapatite (GelMA/ICA@MSN/HAp) scaffold designed to recruit bone marrow mesenchymal stem cells (BMSCs), human umbilical vein endothelial cells (HUVECs), and lymphatic endothelial cells (LECs), enabling these cells to self-assemble into "cell islands" that coordinate tissue regeneration. The scaffold exhibits excellent biocompatibility, biodegradability, and sustained cytokine release. In vitro, it promotes the migration, proliferation, and lineage-specific differentiation of BMSCs, HUVECs, and LECs. In an osteoporotic bone defect model, the scaffold significantly enhances new bone formation, supports vascular remodeling by recruiting HUVECs, and induces lymphatic maturation via LECs, accompanied by upregulation of bone morphogenetic protein 2, vascular endothelial growth factor, and prospero homeobox protein 1. Transcriptomic analysis identifies activation of the hypoxia-inducible factor 1 alpha (HIF-1α) signaling pathway as crucial to these effects. Mechanistically, LECs-derived conditioned medium stimulates HUVECs angiogenesis and BMSCs osteogenesis by inducing HIF-1α mediated mitochondrial metabolic reprogramming. This is the first study to integrate lymphatic modulation into scaffold design for bone repair, achieving osteo-angio-lymphogenic coupling and establishing a novel organoid model for bone regeneration.

14 October 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
WZWenxing Zeng
Wenxing Zeng
SJShan Jiang
Shan Jiang
DCDejun Cun
Dejun Cun
FHFeng Huang
Feng Huang
ZJZiWei Jiang
ZiWei Jiang
Background: Type 2 diabetes (T2D) is a growing global health concern. While micronutrients are crucial for physiological functions and metabolic balance, their precise links to T2D are not fully understood.Methods: We investigated the causal relationships between 15 key micronutrients and T2D risk using both univariate and multivariate Mendelian randomization (MR) methods. Our analysis leveraged data from a large prospective cohort genome-wide association study (GWAS) on these micronutrients and T2D. We employed MR techniques such as inverse variance weighting (IVW), MR Egger, weighted median, and simple models. Multivariate analysis adjusted for diabetes-related factors like body mass index (BMI) and hypertension to assess the independent effects of micronutrients, particularly selenium, on T2D risk.Results: Selenium intake was associated with an increased risk of T2D, with an odds ratio (OR) of 1.045, a 95% confidence interval (CI) ranging from 1.009 to 1.082, and a P-value of 0.015. This association was consistent in multivariate analyses, suggesting an independent effect of selenium on T2D risk after adjusting for confounders.Conclusion: Our study presents novel evidence of a positive correlation between selenium intake and T2D risk, underscoring the importance of micronutrients in diabetes prevention and treatment strategies. Further research is necessary to confirm these findings and to clarify the specific biological mechanisms through which selenium influences diabetes risk.

9 April 2024 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
WZWenxing Zeng
Wenxing Zeng
YWYuheng Wu
Yuheng Wu
XLXiaoye Liang
Xiaoye Liang
DCDejun Cun
Dejun Cun
LMLuyao Ma
Luyao Ma
ZJZiWei Jiang
ZiWei Jiang
Background: Recent studies have emphasized the role of gut microbiota in the onset and progression of osteomyelitis. However, the exact types of gut microbiota and their mechanisms of action remain unclear. Additionally, there is a lack of theoretical support for treatments that improve osteomyelitis by altering the gut microbiota.Methods: In our study, we utilized the largest genome-wide association study (GWAS) meta-analysis to date from the MiBioGen consortium, involving 13,400 participants. The GWAS data for osteomyelitis were sourced from the UK Biobank, which included 4,836 osteomyelitis cases and 486,484 controls. We employed a two-sample Mendelian randomization framework for a detailed investigation into the causal relationship between gut microbiota and osteomyelitis. Our methods included inverse variance weighting, MR-Egger, weighted median, and weighted mode approaches. Additionally, we applied Cochran’s Q statistic to assess the heterogeneity of the instrumental variable.Results: At the class level, Bacilli and Bacteroidia were positively correlated with the risk of osteomyelitis. At the order level, only Bacteroidales showed a positive association with osteomyelitis. At the genus level, an increased abundance of Butyricimonas, Coprococcus3, and Tyzzerella3 was positively associated with the risk of osteomyelitis, whereas Lachnospira was negatively associated. Sensitivity analyses showed no evidence of heterogeneity or pleiotropy.Conclusion: This study reveals that classes Bacilli and Bacteroidia, order Bacteroidales, and genera Butyricimonas, Coprococcus3, and Tyzzerella3 are implicated in increasing the risk of osteomyelitis, while the genus Lachnospira is associated with a reduced risk. Future investigations are warranted to elucidate the precise mechanisms through which these specific bacterial groups influence the pathophysiology of osteomyelitis